Delcath Systems (DCTH) Competitors $11.40 -0.19 (-1.64%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$11.01 -0.39 (-3.41%) As of 04:28 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DCTH vs. CDRE, KMTS, TNDM, FNA, INMD, LQDA, MDXG, BLFS, PLSE, and AORTShould you be buying Delcath Systems stock or one of its competitors? The main competitors of Delcath Systems include Cadre (CDRE), Kestra Medical Technologies (KMTS), Tandem Diabetes Care (TNDM), Paragon 28 (FNA), InMode (INMD), Liquidia (LQDA), MiMedx Group (MDXG), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), and Artivion (AORT). These companies are all part of the "medical equipment" industry. Delcath Systems vs. Cadre Kestra Medical Technologies Tandem Diabetes Care Paragon 28 InMode Liquidia MiMedx Group BioLife Solutions Pulse Biosciences Artivion Cadre (NYSE:CDRE) and Delcath Systems (NASDAQ:DCTH) are both small-cap industrials companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, community ranking, valuation, analyst recommendations, risk and dividends. Does the MarketBeat Community prefer CDRE or DCTH? Delcath Systems received 17 more outperform votes than Cadre when rated by MarketBeat users. However, 55.17% of users gave Cadre an outperform vote while only 27.50% of users gave Delcath Systems an outperform vote. CompanyUnderperformOutperformCadreOutperform Votes1655.17% Underperform Votes1344.83% Delcath SystemsOutperform Votes3327.50% Underperform Votes8772.50% Do analysts prefer CDRE or DCTH? Cadre presently has a consensus target price of $37.00, indicating a potential upside of 19.61%. Delcath Systems has a consensus target price of $22.75, indicating a potential upside of 99.56%. Given Delcath Systems' higher possible upside, analysts clearly believe Delcath Systems is more favorable than Cadre.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cadre 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Delcath Systems 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings & valuation, CDRE or DCTH? Cadre has higher revenue and earnings than Delcath Systems. Delcath Systems is trading at a lower price-to-earnings ratio than Cadre, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCadre$567.56M2.21$38.64M$0.9034.37Delcath Systems$37.21M10.24-$47.68M-$0.98-11.63 Is CDRE or DCTH more profitable? Cadre has a net margin of 6.34% compared to Delcath Systems' net margin of -150.70%. Cadre's return on equity of 12.88% beat Delcath Systems' return on equity.Company Net Margins Return on Equity Return on Assets Cadre6.34% 12.88% 6.06% Delcath Systems -150.70%-338.16%-104.02% Do institutionals and insiders hold more shares of CDRE or DCTH? 44.0% of Cadre shares are held by institutional investors. Comparatively, 61.1% of Delcath Systems shares are held by institutional investors. 37.0% of Cadre shares are held by company insiders. Comparatively, 17.9% of Delcath Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more risk & volatility, CDRE or DCTH? Cadre has a beta of 1.33, suggesting that its stock price is 33% more volatile than the S&P 500. Comparatively, Delcath Systems has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Does the media prefer CDRE or DCTH? In the previous week, Cadre had 1 more articles in the media than Delcath Systems. MarketBeat recorded 6 mentions for Cadre and 5 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 1.37 beat Cadre's score of 0.71 indicating that Delcath Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cadre 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Delcath Systems 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryCadre beats Delcath Systems on 11 of the 17 factors compared between the two stocks. Remove Ads Get Delcath Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for DCTH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DCTH vs. The Competition Export to ExcelMetricDelcath SystemsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$381.14M$4.07B$5.33B$7.57BDividend YieldN/A39.49%5.11%4.32%P/E Ratio-8.4427.6321.6617.82Price / Sales10.2450.21373.3994.61Price / CashN/A51.0838.1534.64Price / Book15.835.826.474.00Net Income-$47.68M$67.09M$3.20B$247.23M7 Day Performance-0.09%-0.17%2.86%1.45%1 Month Performance-9.38%-3.20%-8.56%-6.24%1 Year Performance141.01%14.84%10.58%0.60% Delcath Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DCTHDelcath Systems3.1032 of 5 stars$11.40-1.6%$22.75+99.6%+134.1%$381.14M$37.21M-8.4460News CoveragePositive NewsGap DownCDRECadre3.4227 of 5 stars$28.30+0.5%$37.00+30.7%-7.8%$1.15B$567.56M34.102,240KMTSKestra Medical TechnologiesN/A$22.78-2.1%$27.67+21.5%N/A$1.13B$45.82M0.00300Earnings ReportQuiet Period ExpirationNews CoverageTNDMTandem Diabetes Care4.2123 of 5 stars$16.85-0.2%$45.38+169.3%-44.4%$1.12B$940.20M-8.732,600News CoveragePositive NewsFNAParagon 281.463 of 5 stars$13.04-0.1%$14.20+8.9%+32.0%$1.09B$256.18M-17.61343,000Short Interest ↓News CoverageHigh Trading VolumeINMDInMode2.2432 of 5 stars$15.40-2.0%$22.25+44.5%-12.9%$1.07B$394.82M6.55480Analyst ForecastNews CoverageLQDALiquidia2.2574 of 5 stars$12.43-3.6%$26.63+114.2%-0.6%$1.06B$14.00M-7.6350High Trading VolumeMDXGMiMedx Group3.1901 of 5 stars$7.09+0.4%$12.00+69.3%+7.1%$1.04B$348.88M12.89870Positive NewsBLFSBioLife Solutions2.2077 of 5 stars$21.94+5.1%$31.17+42.1%+43.0%$1.03B$82.25M-20.70440High Trading VolumePLSEPulse Biosciences1.1674 of 5 stars$15.16+0.5%N/A+117.8%$1.02B$700,000.000.00140Positive NewsAORTArtivion2.5719 of 5 stars$23.05-0.7%$31.40+36.2%+13.1%$969.16M$388.54M-1,152.451,300News CoveragePositive NewsGap Down Remove Ads Related Companies and Tools Related Companies Cadre Competitors Kestra Medical Technologies Competitors Tandem Diabetes Care Competitors Paragon 28 Competitors InMode Competitors Liquidia Competitors MiMedx Group Competitors BioLife Solutions Competitors Pulse Biosciences Competitors Artivion Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DCTH) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredRadical shift coming to the stock market (read this ASAP)This is an urgent warning for all American investors … In a matter of days, we could see a radical shift in...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Delcath Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Delcath Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy DCTH Stock Free DCTH Stock Alerts